Full Articles

News & Publications

2023

SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial

Papadopoulou, A., Karavalakis, G., Papadopoulou, E., et al. INat Med. 2023 Jul 17. https://doi.org/10.1038/s41591-023-02480-8

2023

Time From Marketing Authorization to Reimbursement of Medicines in Greece After the Introduction of the Health Technology Assessment Process From July 2018 to April 2022

Beletsi, A., Stefanou, G., Kourlaba, G. Value Health Reg Issues. 2023 Jul; 36:58-65. https://doi.org/10.1016/j.vhri.2023.03.001

2023

Cardiorenal multimorbidity in hospitalized cardiology patients: The Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study

Leontsinis I, Farmakis D, Avramidis D, et. al. Hellenic J Cardiol. 2023 May 4:S1109-9666(23)00053-2. https://doi.org/10.1016/j.hjc.2023.03.006

2023

Editorial: The UN international day of families: neurodegeneration as a result of genetic inheritance

Pacheva IH, Attili D and Ravanidis S. Front. Aging Neurosci., Sec. Neurocognitive Aging and Behavior. 2023 Oct 6; 15. https://doi.org/10.3389/fnagi.2023.1291613

2023

CDK4/6 inhibitors and SSRIs/SNRIs: A brief review of their safety profiles focusing on potential drug interactions

Lampropoulou DI, Lioliou K, Zerva E, Madia X, Vardoulaki D, Aravantinos G, Filippou D, Gazouli M. Topics in Biomedical Research and Education. 2023 Mar 22;1(1):24-32. https://reibs.org.gr/wp-content/uploads/2023/03/8ToBRE_0010-2023.pdf

2023

The Role of EMT-Related lncRNAs in Ovarian Cancer

Lampropoulou DI, Papadimitriou M, Papadimitriou C, Filippou D, Kourlaba G, Aravantinos G, Gazouli M. Int J Mol Sci. 2023 Jun 13;24(12):10079. https://doi.org/10.3390/ijms241210079

2022

Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer.

Pliakou E, Lampropoulou DI, Dovrolis N, Chrysikos D, Filippou D, Papadimitriou C, Vezakis A, Aravantinos G, Gazouli M. Int J Mol Sci. 2022 Dec 20;24(1):46. https://doi.org/10.3390/ijms24010046

2022

Prevalence of adult self-reported atopic dermatitis in Greece: results from a nationwide survey

Stefanou, G., Gregoriou, S., Kontodimas, S., Sfaelos, K., Vakirlis, E., Kourlaba, G. Eur J Dermatol 2022 Sep 1;32(5):597-606. https://doi.org/10.1684/ejd.2022.4335

2022

Burden of Atopic Dermatitis in Adults in Greece: Results from a Nationwide Survey

Gregoriou S, Stefanou G, Kontodimas S, Sfaelos K, Zavali M, Vakirlis E, Kourlaba G. J Clin Med. 2022 Aug 16;11(16):4777. https://doi.org/10.3390/jcm11164777

2022

Patients' satisfaction, unmet needs and treatment benefits in moderate to severe psoriasis in Greece: results from a cross-sectional survey

Stefanou, G., Kourlaba, G., Vamvakousis, E., Koukopoulou, S., Yfantopoulos, J. Ital J Dermatol Venerol. 2022 Jun 6. doi: 10.23736/S2784-8671.22.07258-9.

2021

Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece

Vellopoulou K., Stefanou G., Tzanetakos C., Boubouchairopoulou N., Nakou M., Gourzoulidis G., Kourlaba G. European journal of gastroenterology & hepatology vol. 33,3 (March 2021): 325-333. https://doi.org/10.1097/MEG.0000000000001916

2021

End-of-life cost for lung cancer patients in Greece: a hospital-based retrospective study

Kokkotou E., Stefanou G., Syrigos N., Gourzoulidis G., Ntalakou E., Apostolopoulou A., Charpidou A., Kourlaba G. Journal of comparative effectiveness research vol. 10,4 (19 February 2021): 315-324. https://doi.org/10.2217/cer-2020-0167

2021

Willingness of Greek general population to get a COVID-19 vaccine

Kourlaba G., Kourkouni E., Maistreli S., Tsopela C. G., Molocha N. M., Triantafyllou C., Koniordou M., Kopsidas I., Chorianopoulou E., Maroudi-Manta S., Filippou D.,Zaoutis T. E. Global health research and policy vol. 6,1 (29 January 2021) https://doi.org/10.1186/s41256-021-00188-1

2021

Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece

Gourzoulidis G., Tzanetakos C., Ioannidis I., Tsimihodimos V., Diogo V., Karpouzos G., Papageorgiou G., Kourlaba G. Clinical drug investigation vol. 41,4 (09 March 2021): 371-380. https://doi.org/10.1007/s40261-021-01013-w

2021

Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastroesophageal junction, among patients previously treated in Greece

Gourzoulidis G., Koulentaki M., Koumarianou A., Samadas E., Androulakis, N., Xynogalos S., Papakotoulas P., Boukovinas I., Karamouzis M., Souglakos J., Chotzagiannoglou V., Beletsi A., & Kourlaba G. Expert review of Pharmacoeconomics & outcomes research (06 May 2021): 1–11. Advance online publication. https://doi.org/10.1080/14737167.2021.1921576

2020

Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in Greece

Kourlaba G, Stefanou G, Tsalamandris S, Oikonomou E, Papageorgiou G, Nikas N, Tousoulis D, Maniadakis N. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 62,3 (May–June 2021): 234-240. https://doi.org/10.1016/j.hjc.2020.06.013

2020

Length of stay, cost, and mortality of healthcare-acquired bloodstream infections in children and neonates: A systematic review and meta-analysis

Karagiannidou S, Triantafyllou C, Zaoutis TE, Papaevangelou V, Maniadakis N, Kourlaba G. Infection control and hospital epidemiology vol. 41,3 (03 January 2020): 342-354. https://doi.org/10.1017/ice.2019.353

2019

Lung cancer patients’ journey from first symptom to treatment: Results from a Greek registry

Kourlaba G, Gkiozos I, Kokkotou E, Stefanou G, Papaspiliou A, Syrigos K. Cancer epidemiology vol. 60 (June 2019): 193-200. https://doi.org/10.1016/j.canep.2019.04.014